← Evidence map

Observational studyNeurology. Clinical practice2026

Infection Risk During Rituximab Therapy in Multiple Sclerosis: Effect of Dosing Interval and Age.

Gorm Pihl-Jensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42854181